Endava (NYSE: DAVA) experienced a sharp 25% stock decline on September 22, 2026, after announcing that its CFO Mark Thurston was placed on administrative leave and an internal investigation was initiated regarding accounting treatment of customer and supplier agreements. The company also delayed its quarterly and...
Endava plc announced that its CFO Mark Thurston was placed on administrative leave pending an investigation by independent outside counsel regarding the company's accounting treatment of customer and supplier agreements. The announcement triggered a significant stock price decline of 24.2% during intraday trading on...
Endava experienced a significant stock decline of 29.5% after reporting Q1 fiscal 2026 results that missed previous guidance, with sales declining 8.7% year-over-year and management lowering annual performance targets.
Endava reported disappointing Q1 fiscal 2026 results, with revenue of 178 million pounds, down 9% year-over-year, and missed analyst expectations. The stock dropped over 26% due to unexpected client credits and strategic pipeline opportunities not converting to revenue.
Endava reported a disappointing fourth quarter with declining revenue, reduced headcount, and a shrinking client base. The company's stock has dropped significantly, with management attributing challenges to macro economic conditions.
US stock futures traded higher on Wednesday, with the S&P 500 and Nasdaq 100 indices turning positive for the year. Analysts noted a bullish signal in the market, with over 60% of S&P 500 components reaching new 20-day highs, which has historically been followed by strong performance.
US stock futures traded lower on Wednesday, but the S&P 500 and Nasdaq 100 indices turned positive for the year after Tuesday's advance. Analysts noted a bullish signal in the market, with over 60% of S&P 500 components reaching new 20-day highs, which has historically been followed by strong performance.
Endava, plc (DAVA) is facing a securities fraud lawsuit alleging that the company failed to disclose declining demand, delayed or canceled projects, and the resulting adverse impact on its fiscal 2023 and 2024 revenue and earnings.
Law Offices of Howard G. Smith has filed class action lawsuits on behalf of shareholders of Methode Electronics, Endava, Outset Medical, and Sage Therapeutics. The lawsuits allege that the companies made false or misleading statements about their business operations and prospects.
Endava, PLC investors are advised to contact the Portnoy Law Firm to recover losses from a class action lawsuit. The lawsuit alleges that Endava made misleading statements about its business, leading to a significant decline in its stock price.
Endava plc (NYSE: DAVA) investors who purchased securities between May 23, 2023 and February 28, 2024 are encouraged to join a securities class action lawsuit before the October 25, 2024 deadline. The lawsuit alleges that Endava made false and/or misleading statements about declining demand, delayed or canceled...
Rosen Law Firm, a global investor rights law firm, is reminding purchasers of Endava plc (NYSE: DAVA) securities between May 23, 2023 and February 28, 2024 of the important October 25, 2024 lead plaintiff deadline in a securities class action lawsuit. The lawsuit alleges that Endava made false and/or misleading...
Endava, plc (DAVA) is facing a class action lawsuit due to declining demand, delayed or canceled projects, and lower-than-expected revenue and earnings in fiscal 2023 and 2024.
Faruqi & Faruqi, LLP is investigating potential claims against Endava plc (NYSE: DAVA) for making false and/or misleading statements about the company's business, operations, and prospects, which led to significant declines in the stock price.
Rosen Law Firm is encouraging investors who purchased Endava plc (NYSE: DAVA) securities between May 23, 2023 and February 28, 2024 to join a class action lawsuit, as the company allegedly made false and/or misleading statements about its business and financial performance.
Bernstein Liebhard LLP reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit against Endava, plc. The lawsuit alleges that Endava made misrepresentations concerning demand for its services within certain verticals.
Rosen Law Firm is encouraging investors who purchased Endava plc (NYSE: DAVA) securities between May 23, 2023 and February 28, 2024 to seek legal counsel before the October 25, 2024 lead plaintiff deadline in a securities class action lawsuit.
Endava PLC (DAVA) is facing a class action lawsuit alleging that the company misled investors about its business prospects, leading to a significant drop in its stock price.
Headlines via Polygon.io. Links open the original publisher.